Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$3.8B
239M shares
52-week range
$6.65 – $17.09
88% from low
Sector
SERVICES-NURSING & PERSONAL CARE FACILITIES
Exchange
NYSE
CS
Borrow rate
0.37%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.52B | $4.06B | $3.02B | $2.75B | $2.74B | $2.87B | $2.98B | $3.12B |
| Cost of revenue | $2.45B | $3.18B | $2.32B | $2.26B | $2.23B | $2.12B | $2.18B | $2.48B |
| Gross profit | $1.07B | $876.5M | $700.6M | $488.6M | $513.9M | $744.7M | $807.4M | $645.0M |
| Gross margin | 30.3% | 21.6% | 23.2% | 17.8% | 18.7% | 26.0% | 27.1% | 20.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$594.2M | −$44.5M | −$97.7M | −$216.9M | −$42.7M | $18.4M | $46.5M | $17.2M |
| EBITDA | $505.1M | $361.3M | $256.7M | $425.1M | $319.9M | $369.3M | $420.8M | $347.7M |
| Net income | −$528.3M | −$267.9M | $82.0M | −$99.3M | −$238.4M | −$189.0M | −$201.9M | −$262.7M |
| Net margin | -15.0% | -6.6% | 2.7% | -3.6% | -8.7% | -6.6% | -6.8% | -8.4% |
| EPS (diluted) | -2.82 | -1.44 | 0.44 | -0.54 | -1.25 | -0.84 | -0.89 | -1.11 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.0B | $-0.14 | $-0.14–$-0.14 | 2 |
| 2027 | $3.1B | $0.14 | $0.13–$0.14 | 3 |
| 2028 | $3.2B | $0.40 | $0.37–$0.43 | 2 |
Forward consensus · source: Financial Modeling Prep
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
www.brookdale.comNo one on the platform currently holds BKD.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 7,663,564 | $104.8M |
No one on the platform has traded BKD yet.
| -0.00% |
| $1.9B |
| — |
| COGTCogent Biosciences, Inc. | $38.74 | +1.68% | $6.6B | — |
| DNLIDenali Therapeutics Inc. | $25.89 | +1.25% | $4.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.2× sales vs its 0.5× historical median P/S.
Fair value ≈ $5.99 · price $15.86 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$BKD is Don't Take a Loss! Target is $16.25. https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/HLW6Ms6wEs92
View on StockTwits ↗$BKD Picked up a lot at $11.85 a couple of weeks ago. This has a way to go.
View on StockTwits ↗Wall St is expecting -0.07 EPS for $BKD Q2 [Reporting 08/10 AMC] http://www.estimize.com/intro/bkd?chart=historical&metric_name=eps&utm_con
View on StockTwits ↗Wall St is expecting -0.07 EPS for $BKD Q2 [Reporting 08/10 AMC] http://www.estimize.com/intro/bkd?chart=historical&metric_name=eps&utm_con
View on StockTwits ↗$BKD Share Price: $13.30 Contract Selected: Dec 18, 2026 $12.0 Calls Buy Zone: $1.15 – $1.42 Target Zone: $1.87 – $2.28 Potential Upside: 54% ROI Time to Expiration: 210 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$BKD Outstanding article that hits the mark on BKD's current state. So if you want to refresh your BKD insights or learn about BKD from scratch, this is a must read. https://everyticker.com/quote/BKD/analysis/brookdale-s-demographic-dividend-how-portfolio-surgery-and-operational-focus-are-creating-a-senior-living-inflection-point-nyse-bkd
View on StockTwits ↗https://marketbeat.com/a/8644328/ $BKD Brookdale Senior Living Q1 Earnings Call Highlights
View on StockTwits ↗$BKD Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 up 89.29% YoY • Reported revenue of $764.86M down -6.02% YoY • Brookdale Senior Living Inc. is reiterating its full year 2026 guidance, expecting RevPAR year-over-year growth of 8.0% to 9.0% and Adjusted EBITDA in the range of $502 million to $516 million.
View on StockTwits ↗Wall St is expecting -0.02 EPS for $BKD Q1 [Reporting 05/06 AMC] http://www.estimize.com/intro/bkd?chart=historical&metric_name=eps&utm_con
View on StockTwits ↗$BKD just checking things out in here to see what’s going on. Is it a good time?
View on StockTwits ↗Wall St is expecting -0.02 EPS for $BKD Q1 [Reporting 05/12 AMC] http://www.estimize.com/intro/bkd?chart=historical&metric_name=eps&utm_con
View on StockTwits ↗$BKD Dear wifey said we should open an senior care place. I said "that sounds like a lot of hard work. How about I just buy some shares in one instead." Nibbled on this demographic play today. Why the 10% dip recently? Nobody liked last ER? Think I'll average into a position this month.
View on StockTwits ↗$BKD Bought some more today. Good macro tailwinds (baby boomers turning 80 and constrained supply) and idiosyncratic catalysts (new management, higher occupancy, operational excellence) $SPY
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.